Solid organ transplantation and HIV infection

Area of Science:

• Immunology
• Infectious Diseases
• Transplant Surgery

Background:

• Historically, HIV infection was an absolute contraindication for solid organ transplantation.
• Highly active antiretroviral therapy (HAART) has dramatically improved survival and reduced morbidity in HIV-infected individuals.
• There is a growing population of HIV-positive patients with end-stage organ diseases requiring treatment.

Purpose of the Study:

• To evaluate the feasibility and outcomes of solid organ transplantation in HIV-infected patients.
• To determine if HIV-positive patients can achieve outcomes comparable to HIV-negative patients post-transplant.
• To advocate for considering transplantation as a treatment option for select HIV-positive individuals.

Main Methods:

• Review of current data and outcomes of solid organ transplantation in HIV-infected patients.
• Comparison of transplant success rates and complications between HIV-positive and HIV-negative patient cohorts.
• Analysis of the impact of highly active antiretroviral therapy (HAART) on transplant outcomes.

Main Results:

• Outcomes of solid organ transplantation in HIV-infected patients are comparable to those in HIV-negative populations.
• Successful transplantation is achievable in carefully selected HIV-positive individuals.
• Advances in HIV management have mitigated risks associated with transplantation.

Conclusions:

• Solid organ transplantation should be considered a potential treatment option for carefully selected HIV-positive patients with end-stage organ disease.
• The improved management of HIV infection has shifted the paradigm regarding transplantation eligibility.
• Further research and clinical consideration are warranted for expanding transplantation access to HIV-positive individuals.